UNICREDIT BANK/CALL/FRESENIUS/35/0.1/18.12.24 Stock

Warrant

DE000HC37YH3

Market Closed - BOERSE MUENCHEN 15:40:21 2024-07-01 EDT
0.039 EUR +11.43% Intraday chart for UNICREDIT BANK/CALL/FRESENIUS/35/0.1/18.12.24
Current month+11.43%
1 month-43.48%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-01 0.039 +11.43%
24-06-28 0.035 0.00%
24-06-27 0.035 0.00%
24-06-26 0.035 -5.41%
24-06-25 0.037 -9.76%

Real-time BOERSE MUENCHEN

Last update July 01, 2024 at 03:40 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying FRESENIUS SE & CO. KGAA
IssuerLogo Issuer UniCredit UniCredit
WKN HC37YH
ISINDE000HC37YH3
Date issued 2023-01-16
Strike 35
Maturity 2024-12-18 (170 Days)
Parity 10 : 1
Emission price 0.31
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.34
Lowest since issue 0.029
Delta0.15x
Omega 11.69
Premium25x
Gearing75.47x
Moneyness 0.8086
Difference Strike 6.7
Difference Strike %+19.14%
Spread 0.005
Spread %12.50%
Theoretical value 0.0380
Implied Volatility 26.07 %
Total Loss Probability 88.28 %
Intrinsic value 0.000000
Present value 0.0380
Break even 35.38 €
Theta-0x
Vega0x
Rho0x

Company Profile

Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - hospital administration and engineering (64.3%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (35.7%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. Net sales are distributed geographically as follows: Europe (72.4%), North America (12.3%), Asia/Pacific (7.3%), Latin America (6.4%) and Africa (1.6%).
Sector
-
More about the company

Ratings for Fresenius SE & Co. KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius SE & Co. KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
28.3 EUR
Average target price
37.26 EUR
Spread / Average Target
+31.65%
Consensus